Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
INDIA — Biocon has announced the signing of a semi-exclusive partnership agreement with Zentiva, a leading pharmaceutical company in Europe, for the commercialization of its vertically integrated, complex formulation, Liraglutide.…
Read More
INDIA — Biosimilars manufacturing arm of Biocon Ltd, Biocon Biologics, has completed the acquisition of Viatris’ global biosimilars business for US$3 billion. As per the statement issued by the parent…
Read More
INDIA – The Competition Commission of India (CCI) has approved the merger of Covidshield Technologies Pvt Ltd (CTPL), a wholly owned subsidiary of Serum Institute Life Sciences Pvt Ltd (SILS),…
Read More
MALAYSIA – The Malaysian government has awarded Biocon Biologics’ subsidiary a contract worth US$90 million (approximately Rs.688 crore) to supply of recombinant human (rh)-insulin brand, Insugen for the treatment of…
Read More
INDIA – Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS), a subsidiary of Serum Institute of India (SII), have announced a…
Read More